# Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions

> **NCT03421834** · NA · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 60 (actual)

## Conditions studied

- Ventricular Tachycardia
- Ischemic Cardiomyopathy

## Interventions

- **PROCEDURE:** Catheter ablation of ventricular tachycardia
- **DRUG:** Optimal medical treatment

## Key facts

- **NCT ID:** NCT03421834
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-06
- **Primary completion:** 2024-01-04
- **Final completion:** 2024-01-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03421834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03421834, "Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03421834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*